Equities

Rohto Pharmaceutical Co Ltd

Rohto Pharmaceutical Co Ltd

Actions
  • Price (USD)21.54
  • Today's Change0.00 / 0.00%
  • Shares traded3.99k
  • 1 Year change+2.97%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 13:05 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments89,21079,95172,791
Total Receivables, Net69,11560,65651,682
Total Inventory46,65741,06233,527
Prepaid expenses------
Other current assets, total9,7778,5776,306
Total current assets214,759190,246164,306
Property, plant & equipment, net68,60766,18262,839
Goodwill, net2,2852,5642,954
Intangibles, net6,9326,9976,587
Long term investments44,33733,63728,132
Note receivable - long term5,9905,687--
Other long term assets(604)(1007)10,058
Total assets346,175309,677274,876
LIABILITIES
Accounts payable21,12318,71816,269
Accrued expenses27,29225,54419,354
Notes payable/short-term debt1,3736940
Current portion long-term debt/capital leases8,0927,6138,033
Other current liabilities, total29,20727,59327,832
Total current liabilities87,08780,16271,488
Total long term debt6,6888,70013,350
Total debt16,15317,00721,383
Deferred income tax1,5971,173--
Minority interest7105,5085,594
Other liabilities, total3,7674,5646,044
Total liabilities99,849100,10796,476
SHAREHOLDERS EQUITY
Common stock6,5046,5046,504
Additional paid-in capital4,5165,2925,791
Retained earnings (accumulated deficit)209,781184,387162,686
Treasury stock - common(4939)(4938)(4936)
Unrealized gain (loss)11,2767,9515,992
Other equity, total19,18810,3742,363
Total equity246,326209,570178,400
Total liabilities & shareholders' equity346,175309,677274,876
Total common shares outstanding228228228
Treasury shares - common primary issue8.048.048.04
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.